- Home
- HMNF vs VIGL Comparison
HMNF vs VIGL Comparison
Compare HMNF & VIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HMNF
- VIGL
- Stock Information
- Founded
- HMNF 1934
- VIGL 2020
- Country
- HMNF United States
- VIGL United States
- Employees
- HMNF N/A
- VIGL N/A
- Industry
- HMNF Savings Institutions
- VIGL Biotechnology: Pharmaceutical Preparations
- Sector
- HMNF Finance
- VIGL Health Care
- Exchange
- HMNF Nasdaq
- VIGL Nasdaq
- Market Cap
- HMNF 119.4M
- VIGL 125.3M
- IPO Year
- HMNF 1994
- VIGL 2022
- Fundamental
- Price
- HMNF $28.23
- VIGL $3.44
- Analyst Decision
- HMNF
- VIGL Buy
- Analyst Count
- HMNF 0
- VIGL 5
- Target Price
- HMNF N/A
- VIGL $16.60
- AVG Volume (30 Days)
- HMNF 4.9K
- VIGL 94.8K
- Earning Date
- HMNF 10-17-2024
- VIGL 11-05-2024
- Dividend Yield
- HMNF 1.47%
- VIGL N/A
- EPS Growth
- HMNF N/A
- VIGL N/A
- EPS
- HMNF 1.19
- VIGL N/A
- Revenue
- HMNF $38,260,000.00
- VIGL N/A
- Revenue This Year
- HMNF N/A
- VIGL N/A
- Revenue Next Year
- HMNF N/A
- VIGL N/A
- P/E Ratio
- HMNF $22.83
- VIGL N/A
- Revenue Growth
- HMNF N/A
- VIGL N/A
- 52 Week Low
- HMNF $17.60
- VIGL $2.47
- 52 Week High
- HMNF $28.25
- VIGL $9.24
- Technical
- Relative Strength Index (RSI)
- HMNF 62.56
- VIGL 50.19
- Support Level
- HMNF $26.60
- VIGL $3.20
- Resistance Level
- HMNF $28.11
- VIGL $3.48
- Average True Range (ATR)
- HMNF 0.72
- VIGL 0.18
- MACD
- HMNF 0.12
- VIGL 0.02
- Stochastic Oscillator
- HMNF 99.28
- VIGL 46.58
About HMNF HMN Financial Inc.
HMN Financial Inc is a stock savings bank holding company of Home Federal Savings Bank. The bank is engaged in community banking and operates retail banking and loan production facilities in Minnesota, Iowa, and Wisconsin. It is involved in the business of attracting deposits from the general public and businesses and using such deposits to originate single-family residential, commercial real estate, and multi-family mortgage loans as well as consumer, construction, and commercial business loans. The bank also invests in mortgage-backed and related securities, U.S. government agency obligations, and other permissible investments. Its products and services include checking and savings accounts, cash deposits, online services, and credit cards among others.
About VIGL Vigil Neuroscience Inc.
Vigil Neuroscience Inc is a microglia-focused therapeutics company treating both rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel cells of the brain's immune system. It is utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities to rapidly deliver precision-based therapies to improve the lives of patients and families. Its clinical candidate, iluzanebart, is currently being studied in IGNITE, a Phase 2 PoC trial and the first-ever interventional trial in ALSP patients. The company is also developing VG-3927, an orally available small molecule TREM2 agonist for the treatment of common neurodegenerative diseases associated with microglial dysfunction.